Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Phillip Callery, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Mark Callery and Douglas Pleskow.
Mark Callery
Connection Strength
0.274
Douglas Pleskow
  1. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e615-22.
    View in: PubMed
    Score: 0.118
  2. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. Clin Cancer Res. 2022 02 15; 28(4):708-718.
    View in: PubMed
    Score: 0.062
  3. Hemorrhage after pancreaticoduodenectomy: does timing matter? HPB (Oxford). 2016 10; 18(10):861-869.
    View in: PubMed
    Score: 0.042
  4. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):735-42.
    View in: PubMed
    Score: 0.027
  5. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1373-6.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.